Warning! GuruFocus detected
2 Severe warning signs
with BIM.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
BioMerieux SA
ISIN : FR0013280286
Share Class Description:
XPAR:BIM: Ordinary SharesCompare
Compare
Traded in other countries / regions
BIM.France0RUG.UKBMXMF.USAEYWN.GermanyBIM.Austria Index Membership
STOXX Europe 600iShares MSCI ACWI Ex US Index FundSTOXX Europe 600 IPO Date
2004-06-07Description
BioMĂ©rieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (34% of 2023 sales), microbiology (39%), immunoassays (10%), and industrial applications (about 17%). The Amercas account for the largest portion of the firm's revenue (45%), followed by Europe, the Middle East, and Africa (31%), and Asia-Pacific (16%). BioMĂ©rieux is headquartered in Marcy-l'Etoile, France.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.92 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 0.54 | |||||
| Interest Coverage | 125.45 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 6.61 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.7 | |||||
| 3-Year EBITDA Growth Rate | -4.1 | |||||
| 3-Year EPS without NRI Growth Rate | -11.4 | |||||
| 3-Year FCF Growth Rate | -15.5 | |||||
| 3-Year Book Growth Rate | 10.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 15.45 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 7.71 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.35 | |||||
| 9-Day RSI | 62.88 | |||||
| 14-Day RSI | 59.86 | |||||
| 3-1 Month Momentum % | 10.08 | |||||
| 6-1 Month Momentum % | 5.73 | |||||
| 12-1 Month Momentum % | 12.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | |||||
| Quick Ratio | 1.29 | |||||
| Cash Ratio | 0.4 | |||||
| Days Inventory | 203.99 | |||||
| Days Sales Outstanding | 67.74 | |||||
| Days Payable | 51.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.72 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| 3-Year Dividend Growth Rate | 11.1 | |||||
| Forward Dividend Yield % | 0.77 | |||||
| 5-Year Yield-on-Cost % | 2.69 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 0.87 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.66 | |||||
| Operating Margin % | 15.45 | |||||
| Net Margin % | 10.86 | |||||
| FCF Margin % | 8.08 | |||||
| ROE % | 10.96 | |||||
| ROA % | 7.93 | |||||
| ROIC % | 10.47 | |||||
| 3-Year ROIIC % | -15.99 | |||||
| ROC (Joel Greenblatt) % | 23.98 | |||||
| ROCE % | 13.36 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.43 | |||||
| Forward PE Ratio | 25.65 | |||||
| PE Ratio without NRI | 30.15 | |||||
| Shiller PE Ratio | 33.38 | |||||
| Price-to-Owner-Earnings | 20.85 | |||||
| PEG Ratio | 4.13 | |||||
| PS Ratio | 3.41 | |||||
| PB Ratio | 3.21 | |||||
| Price-to-Tangible-Book | 4.65 | |||||
| Price-to-Free-Cash-Flow | 42.29 | |||||
| Price-to-Operating-Cash-Flow | 20.37 | |||||
| EV-to-EBIT | 23.81 | |||||
| EV-to-Forward-EBIT | 19.96 | |||||
| EV-to-EBITDA | 15.29 | |||||
| EV-to-Forward-EBITDA | 13.01 | |||||
| EV-to-Revenue | 3.48 | |||||
| EV-to-Forward-Revenue | 3.21 | |||||
| EV-to-FCF | 42.11 | |||||
| Price-to-GF-Value | 1.07 | |||||
| Price-to-Projected-FCF | 2.13 | |||||
| Price-to-DCF (Earnings Based) | 1.75 | |||||
| Price-to-DCF (FCF Based) | 2.72 | |||||
| Price-to-Median-PS-Value | 1.03 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.23 | |||||
| Price-to-Graham-Number | 2.53 | |||||
| Price-to-Net-Current-Asset-Value | 14.81 | |||||
| Earnings Yield (Greenblatt) % | 4.2 | |||||
| FCF Yield % | 2.32 | |||||
| Forward Rate of Return (Yacktman) % | 9.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioMerieux SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3,979.9 | ||
| EPS (TTM) (€) | 3.64 | ||
| Beta | 0.92 | ||
| 3-Year Sharpe Ratio | 0.22 | ||
| 3-Year Sortino Ratio | 0.35 | ||
| Volatility % | 22.02 | ||
| 14-Day RSI | 59.86 | ||
| 14-Day ATR (€) | 2.176861 | ||
| 20-Day SMA (€) | 114.945 | ||
| 12-1 Month Momentum % | 12.28 | ||
| 52-Week Range (€) | 88.25 - 120 | ||
| Shares Outstanding (Mil) | 117.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioMerieux SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioMerieux SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioMerieux SA Frequently Asked Questions
What is BioMerieux SA(XPAR:BIM)'s stock price today?
The current price of XPAR:BIM is €117.60. The 52 week high of XPAR:BIM is €120.00 and 52 week low is €88.25.
When is next earnings date of BioMerieux SA(XPAR:BIM)?
The next earnings date of BioMerieux SA(XPAR:BIM) is 2025-09-04.
Does BioMerieux SA(XPAR:BIM) pay dividends? If so, how much?
The Dividend Yield %  of BioMerieux SA(XPAR:BIM) is 0.72% (As of Today), Highest Dividend Payout Ratio of BioMerieux SA(XPAR:BIM) was 0.28. The lowest was 0.05. And the median was 0.15. The  Forward Dividend Yield % of BioMerieux SA(XPAR:BIM) is 0.77%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers